Screener
Olema Pharmaceuticals, Inc. OLMA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $3,719 | $9,253 |
| Current portion of operating lease liability | 956 | 1,124 |
| Other current liabilities | 42,492 | 41,425 |
| Total current liabilities | 47,167 | 51,802 |
| Non-current liabilities: | ||
| Operating lease liabilities, net of current portion | — | 69 |
| Long-term borrowing | 3,000 | 3,000 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s accrued expenses?
- Olema Pharmaceuticals, Inc. (OLMA) reported accrued expenses of $42.49M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Olema Pharmaceuticals, Inc.'s accrued expenses increased by 70.7% year-over-year, from $24.89M to $42.49M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s accrued expenses has grown at a 60.7% compound annual growth rate (CAGR), from $3.87M to $41.43M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Olema Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude